165 related articles for article (PubMed ID: 8836736)
1. DNA binding proteins from keloid fibroblasts form unique complexes with the human fibronectin promoter.
Sible JC; Eriksson E; Oliver N
Gene Expr; 1996; 5(6):269-83. PubMed ID: 8836736
[TBL] [Abstract][Full Text] [Related]
2. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing.
Babu M; Diegelmann R; Oliver N
Mol Cell Biol; 1989 Apr; 9(4):1642-50. PubMed ID: 2524650
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
[TBL] [Abstract][Full Text] [Related]
6. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
8. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites.
Xia W; Kong W; Wang Z; Phan TT; Lim IJ; Longaker MT; Yang GP
Ann Surg; 2007 Nov; 246(5):886-95. PubMed ID: 17968183
[TBL] [Abstract][Full Text] [Related]
9. Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases.
Macarak EJ; Wermuth PJ; Rosenbloom J; Uitto J
Exp Dermatol; 2021 Jan; 30(1):132-145. PubMed ID: 33211348
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin gene transcription is enhanced in abnormal wound healing.
Oliver N; Babu M; Diegelmann R
J Invest Dermatol; 1992 Nov; 99(5):579-86. PubMed ID: 1431220
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
13. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta.
Chung KY; Agarwal A; Uitto J; Mauviel A
J Biol Chem; 1996 Feb; 271(6):3272-8. PubMed ID: 8621730
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A for the treatment of keloids.
Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J
Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin (FN) in hypertrophic scars and keloids.
Kischer CW; Hendrix MJ
Cell Tissue Res; 1983; 231(1):29-37. PubMed ID: 6342808
[TBL] [Abstract][Full Text] [Related]
16. Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element.
Dean DC; McQuillan JJ; Weintraub S
J Biol Chem; 1990 Feb; 265(6):3522-7. PubMed ID: 2137458
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation.
Kim SH; Jung SH; Chung H; Jo DI; Kim CK; Park SH; Won KJ; Jeon HS; Kim B
Arch Dermatol Res; 2014 May; 306(4):347-57. PubMed ID: 24402284
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
20. Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling.
Ashcroft KJ; Syed F; Bayat A
PLoS One; 2013; 8(12):e75600. PubMed ID: 24348987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
